XML 28 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Sep. 30, 2014
Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,911) $ (4,755)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 498 461
Accretion of discount, amortization of premium and changes in accrued interest of marketable securities 44 559
Gain from sale of investments of available-for-sale marketable securities 17 (142)
Stock-based compensation to employees, directors and non-employee consultants 1,060 1,176
Decrease (increase) in OCS receivables 1,812 (2,055)
Decrease (increase) in other accounts receivable 333 (95)
Increase in prepaid expenses (174) (7)
Increase (decrease) in trade payables (989) 247
Increase (decrease) in other accounts payable and accrued expenses (9) 160
Decrease in deferred revenues (95) (474)
Decrease in advance payment from United Therapeutics (29) (37)
Increase in interest receivable on short-term deposits (9)   
Linkage differences and interest on short and long-term restricted lease deposit 37 (168)
Accrued severance pay, net (41) 35
Net cash used in operating activities (3,456) (5,095)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (271) (462)
Repayment of short-term deposits 4,777 7,132
Repayment of (Investment in) long-term deposits 1 (3)
Repayment of long-term restricted deposit    112
Proceeds from sale of available-for-sale marketable securities 37 1,870
Proceeds from redemption of available-for-sale marketable securities 64 394
Investment in available-for-sale marketable securities (92) (4,861)
Net cash provided by investing activities 4,516 4,182
CASH FLOWS FROM FINANCING ACTIVITIES:    
Exercise of warrants 109 509
Net cash provided by financing activities 109 509
Increase (decrease) in cash and cash equivalents 1,169 (404)
Cash and cash equivalents at the beginning of the period 4,493 9,007
Cash and cash equivalents at the end of the period 5,662 8,603
Supplemental disclosure of cash flow activities:    
Taxes paid due to non-deductible expenses 30 31
Supplemental disclosure of non-cash activities:    
Purchase of property and equipment on credit 188 668
Other receivables resulting from exercise of option $ 2